Topics

Diffuse midline glioma | Treatment | Targeted therapy | Nimotuzumab

Home > Publications > Topics > Diffuse midline glioma > Treatment > Targeted therapy > Nimotuzumab

Liu Y, Liu C, Wang G, Tao R, Xu J, Shen L, Wang H, Zhu C, Zhang H, Zeng G, Hong J, Chen B, Wang S, Bao W, Yang J, Lin Q, Li H, Zhang J, Liu S, Zhang W, Chen S, Zhao Y, Tang J, Kou Z, Su J, Sun P, Wang L, Sun X, Ju Y, Ma W, Wang Y, Shi X, Qiu X, Jiang M.
Nimotuzumab Combined With Chemoradiation Therapy in Newly Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma.
Int J Radiat Oncol Biol Phys. 2025 Jun 19:S0360-3016(25)00532-2. doi: 10.1016/j.ijrobp.2025.05.063. PMID: 40536469. Interventional study. ˍ

Crombet Ramos T, Díaz Miqueli A, Pérez Rodríguez R.
Beyond Acute EGFR Blockade: Biological Basis and Clinical Evidence for Long-Term Nimotuzumab Therapy.
Biomedicines. 2026 Jul 14;14(7):1570. doi: 10.3390/biomedicines14071570. PMID: 42512043. ˍ